Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.
@article{Buster2008PeginterferonFT, title={Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.}, author={E. Buster and S. Schalm and H. Janssen}, journal={Best practice & research. Clinical gastroenterology}, year={2008}, volume={22 6}, pages={ 1093-108 } }
The practising clinician is currently faced with a number of effective treatment options for chronic hepatitis B, including two formulations of interferon (standard IFN and pegylated IFN) and five nucleos(t)ide analogues (lamivudine, adefovir, entecavir, telbivudine and tenofovir). Treatment strategies can be divided into those aiming for sustained response after discontinuation of therapy and those that need to be maintained by prolonged antiviral therapy. Sustained response is particularly… CONTINUE READING
Topics from this paper
24 Citations
Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B
- Medicine
- Journal of viral hepatitis
- 2014
- 29
Peginterferon Monotherapy versus Peginterferon and Lamivudine Combination Therapy for Chronic Hepatitis B
- Medicine
- 2014
- Highly Influenced
Sustained immune control in HBeAg-positive patients who switched from entecavir therapy to pegylated interferon-α2a: 1 year follow-up of the OSST study.
- Medicine
- Antiviral therapy
- 2016
- 24
- PDF
Pharmacokinetics and pharmacodynamics of pegylated interferon for the treatment of hepatitis B
- Medicine
- Expert opinion on drug metabolism & toxicology
- 2019
Targeting Host Innate and Adaptive Immunity to Achieve the Functional Cure of Chronic Hepatitis B
- Medicine
- Vaccines
- 2020
- 1
- PDF
Do we need to determine viral genotype in treating chronic hepatitis B?
- Medicine
- Journal of viral hepatitis
- 2010
- 41
References
SHOWING 1-10 OF 99 REFERENCES
Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B.
- Medicine
- Gastroenterology
- 2006
- 408
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.
- Medicine
- The New England journal of medicine
- 2004
- 1,063
- PDF
Lamivudine as initial treatment for chronic hepatitis B in the United States.
- Medicine
- The New England journal of medicine
- 1999
- 1,330
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
- Medicine
- The New England journal of medicine
- 2005
- 1,198
- PDF
Two years of lamivudine therapy in anti‐HBe‐positive patients with chronic hepatitis B
- Medicine
- Journal of viral hepatitis
- 2001
- 56
Peginterferon alpha‐2b is safe and effective in HBeAg‐positive chronic hepatitis B patients with advanced fibrosis
- Medicine
- Hepatology
- 2007
- 104
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.
- Medicine
- The New England journal of medicine
- 2006
- 1,145
- PDF
Hepatitis B: reflections on the current approach to antiviral therapy.
- Medicine
- Journal of hepatology
- 2008
- 166
Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis B
- Medicine
- Journal of viral hepatitis
- 2003
- 448